Chargement en cours...

Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients

mRNA profiles of circulating tumour cells (CTCs) were analysed in patients with triple‐negative breast cancer (TNBC) (pts) before (BT) and after therapy (AT) to identify additional treatment options. 2 × 5 mL blood of 51 TNBC pts and 24 non‐TNBC pts (HR+/HER2−; HR−/HER2+) was analysed for CTCs using...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cell Mol Med
Auteurs principaux: Bittner, Ann‐Kathrin, Keup, Corinna, Hoffmann, Oliver, Hauch, Siegfried, Kimmig, Rainer, Kasimir‐Bauer, Sabine
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7412423/
https://ncbi.nlm.nih.gov/pubmed/32558176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15349
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!